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Herpes simplex virus type 1 (HSV-1) entry into permissive cells involves attachment to cell-surface glycosaminoglycans (GAGs) and fusion of
the virus envelope with the cell membrane triggered by the binding of glycoprotein D (gD) to cognate receptors. In this study, we characterized the
observation that soluble forms of the gD ectodomain (sgD) can mediate entry of gD-deficient HSV-1. We examined the efficiency and receptor
specificity of this activity and used sequential incubation protocols to determine the order and stability of the initial interactions required for entry.
Surprisingly, virus binding to GAGs did not increase the efficiency of sgD-mediated entry and gD-deficient virus was capable of attaching to
GAG-deficient cells in the absence of sgD. These observations suggested a novel binding interaction that may play a role in normal HSV infection.
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Infection of permissive cells by herpes simplex virus type 1
(HSV-1) generally requires virus attachment to the cell surface
and fusion of the viral envelope with the cytoplasmic or
endosomal membrane. HSV attachment involves the coordi-
nated binding of multiple viral glycoproteins to their cognate
cellular receptors. Glycoproteins B (gB) and C (gC) bind to
herparan sulfate (HS) glycosaminoglycan (GAG) side chains of
cell-surface proteoglycans, while glycoprotein D (gD) engages
one of three HSV-1 entry receptors, HVEM (HveA), nectin-1
(HveC), or 3-O-sulfated HS (Geraghty et al., 1998; Montgom-
ery et al., 1996; Shukla et al., 1999). Receptor binding by gD is
believed to set in motion the fusion process, which requires gB
and the gH:gL heterodimer for completion (reviewed in
Campadelli-Fiume et al., 2000; Spear, 2004).
Glycoprotein B and C binding to HS represents approxi-
mately 80% of the HSV-1 binding capacity to fully permissive
cells (Laquerre et al., 1998). Accordingly, mutant viruses
defective for these activities bind to and infect cells with⁎ Corresponding author. Fax: +1 412 624 8997.
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Shieh and Spear, 1994). Likewise, HSV binding and entry are
reduced approximately 10-fold on cells that lack surface HS
(Shieh et al., 1992). It is generally believed that the interaction
of gD with its receptor(s) is responsible for the residual cell-
binding activity of HSV in the absence of cell-surface HS, but
this has not been directly demonstrated. A recent report
suggesting gB binding to a novel receptor (Bender et al.,
2005) illustrates the possibility that other interactions are also
involved.
Mutational analyses and mapping of antibody binding sites
have revealed distinct, but overlapping regions of gD that
contribute to the binding of the different cognate receptors. An
array of gD mutants have been described that are competent for
binding and entry via nectin-1, but not HVEM (Carfi et al.,
2001; Connolly et al., 2003; Krummenacher et al., 1998; Lopez
et al., 2000; Milne et al., 2003; Montgomery et al., 1996;
Warner et al., 1998; Whitbeck et al., 1997). Rare mutants with
the reciprocal profile have now been identified as well
(Connolly et al., 2005; Manoj et al., 2004) (Q. Bai, W. Ali
Shah, J.B. Cohen, R.J. Eisenberg, G.H. Cohen and J.C.
Glorioso, 26th International Herpesvirus Workshop, abstr.
2.10, 2001). In addition, individual antibodies have been
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other receptor (Nicola et al., 1998). Elucidation of the crystal
structures of a C-terminally truncated version of the gD
ectodomain in free form and complexed with HVEM has
identified an N-terminal hairpin domain as a major component
of the HVEM binding site (Carfi et al., 2001, 2002), consistent
with the location of HVEM-specific loss-of-function mutations.
Although the nectin-1 binding site remains poorly defined,
current evidence supports the view that it is formed by several
discontinuous sequences, some shared with the HVEM binding
site, others unique.
Recent studies have identified a region in gD that is required
for virus entry, but not binding of gD to HVEM or nectin-1
(Cocchi et al., 2004; Zago et al., 2004). This region, roughly
spanning amino acids 260–310 in the C-terminal portion of the
ectodomain, was divided into two sub-regions that were found
to bind independently to sequences in the upstream portion of
the gD ectodomain. Importantly, it was shown that these
interactions were disrupted by binding of gD to nectin-1 or
HVEM (Fusco et al., 2005). These observations suggested that
receptor binding liberates the C-terminal portion of the gD
ectodomain for interaction with components of the membrane
fusion machinery, thereby setting in motion the virus entry
process. Compelling support for this model has since been
provided by the elucidation of the structure of the complete
ectodomain of gD, demonstrating multiple contacts between the
C-terminal region and important components of the HVEM and
nectin-1 binding sites in unliganded gD (Krummenacher et al.,
2005).
Cocchi and co-workers reported that the gD ectodomain in
soluble form (gD285t) can mediate entry of gD-deficient HSV-1
into susceptible cells, suggesting that the ectodomain can
interact in trans with the virus (Cocchi et al., 2004). Along with
the demonstration that this activity was abolished by truncation
of the ectodomain at position 260, this result represents
compelling evidence that the proximal target of gD within the
fusion machinery is another viral protein, such as gB or gH.
However, this study did not report whether receptor-deficient
cells were resistant to gD285t-mediated entry, leaving open the
possibility that the soluble molecule did not require activation
by receptor binding to interact with cell-attached virus and
initiate the entry process. In addition, the efficiency of entry was
not addressed, thus prohibiting any conclusions as to whether
the proposed interaction between gD residues 260–285 and a
separate viral component may in fact be the principal signal to
initiate membrane fusion.
We independently observed infection of HSV-1-susceptible
cells by a gD-deficient virus in the presence of soluble gD
ectodomain, in this instance a molecule truncated after residue
287 (sgD287, hereafter also referred to as sgD). To characterize
this activity, we showed that infection was dependent on the
presence of a cell-surface receptor for gD and specific
recognition of this receptor by soluble gD. We acquired data
indicating that sgD287-mediated infection was approximately
10-fold less efficient than infection by gD+ virus, consistent
with the suggestion that the process is comparable to that
initiated by virion gD. Variation of the infection conditionsshowed that exposure of cell-bound sgD to 37 °C impaired entry
of subsequently added virus. We found that this was due to
gradual sgD dissociation from the cells at this temperature in the
absence of virus, indicating that entry requires virus interaction
with receptor-bound sgD at the cell surface. However, since
entry was not abruptly abolished by pre-exposure of cell-bound
sgD to 37 °C, we conclude that the entry-mediating conforma-
tion of sgD was stable as long as the soluble molecule remained
attached to its receptor. Remarkably, we observed that sgD-
mediated gD− virus entry was not dependent on either of the
known mechanisms for HSVattachment to cells, namely gB and
gC binding to cellular GAGs and virion gD binding to cognate
cellular receptors. A novel binding function was suggested by
experiments showing adsorption of gD-deficient virus to GAG-
deficient cells in the absence of sgD. Together, these results
illustrate the utility of soluble gD to explore the early events in
the HSV infectious process.
Results
Soluble gD mediates entry of a gD-deficient virus into
CHO-K1 cells expressing entry receptors
Soluble gD ectodomain, comprised of the first 287 amino
acids of mature gD followed by a histidine tag (sgD287), was
prepared by transfection of 293T cells with a suitable
mammalian expression construct and recovery of the
histidine-tagged products by passage of the growth media
over a Ni2+ affinity column, as previously described (Nakano
et al., 2005). Analysis by SDS-PAGE and Coomassie staining
revealed a single band at a molecular size of approximately
38 kDa for wild-type (wt) sgD287 and two mutants (data not
shown). These products were recognized on Western blots by
both a His tag-specific monoclonal antibody (Fig. 1A) and a
gD-specific polyclonal antibody, R7 (Krummenacher et al.,
2000) (data not shown).
The gD-deficient HSV-1 recombinant KΔUs3-8Z, contain-
ing a lacZ reporter cassette in place of the Us3–Us8 region of
HSV-1 KOS, was described previously (Anderson et al., 2000).
The deletion in this virus extends at both ends beyond the limits
of the complementing region in the genome of VD60 cells and
the virus can therefore be propagated on these cells without
detectable rescue by homologous recombination. KΔUs3-8Z
virions lacking gD were produced by infection of Vero cells
with gD-complemented KΔUs3-8Z, removal of input extra-
cellular virus, and collection of cell lysates 3–5 days later.
HSV-resistant CHO-K1 cells and susceptible derivatives
expressing HVEM or nectin-1 were incubated for 3 h with gD-
deficient KΔUs3-8Z in the presence of sgD287. Entry was
visualized 16 h later by staining the cells for β-galactosidase
activity expressed by the virus. Fig. 1B demonstrates that wt
sgD enabled entry of the gD-deficient virus into CHO-HVEM
and CHO-nectin-1 cells, but not CHO-K1 cells. The degree of
infection increased linearly with both the virus dose and the
amount of sgD (data not shown).
To determine the relative efficiency of infection mediated by
sgD compared to virion gD, we used quantitative TaqMan PCR
Fig. 1. Soluble gD proteins mediate entry of gD-deficient KΔUs3-8Z virus into receptor-positive cells. (A) sgD287, sgD287(L25P), and sgD287(R222N,F223I) were detected on a Western blot using an anti-histidine tag
antibody, as described in Materials and methods. (B) Subconfluent monolayers of CHO-HVEM (1 and 2), CHO-nectin-1 (3 and 4), and CHO-K1 cells (5 and 6) in 96-well plates were incubated with gD-deficient
KΔUs3-8Z in the absence (1, 3, and 5) or presence of 500 ng sgD287 (2, 4, and 6) for 3 h at 37 °C. Infected cells were identified by X-gal staining 16 h after infection. (C) gD-deficient KΔUs3-8Z was incubated with
CHO-HVEM or CHO-nectin-1 cells in the absence (1 and 2) or presence of wild-type sgD287 (3 and 4), sgD287(L25P) (5 and 6), or sgD287(R222N,F223I) (7 and 8) for 3 h at 37 °C. Infected cells were identified by X-gal
staining at 16 h after infection. 479
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Table 1
Incubation protocols for gD-deficient KΔUs3-8Z entry into CHO-HVEM cells
Protocol # Incubation 1 Wash Incubation 2 Wash Infection Entry a
1. Virus+sgD/37 °C +++
2. Virus/37 °C Yes sgD/37 °C +++
3. sgD/37 °C Yes Virus/37 °C −
4. sgD/4 °C Yes Virus/37 °C −
5. sgD/4 °C Yes Virus/4 °C Yes 37 °C ++
a +++, >50% infected cells; ++, 20–50% infected cells; −, <5% infected cells.
480 M. Tsvitov et al. / Virology 360 (2007) 477–491to estimate the number of gD-deficient virus particles used in
our experiments. The results showed a reduction of approxi-
mately 10-fold in transducing events per viral particle for gD-
deficient KΔUs3-8Z in the presence of sgD compared to a
KΔUs3-8Z preparation harvested from gD-complementing
VD60 cells (see Materials and methods). Thus, we estimate
that the efficiency of sgD-mediated infection is approximately
one order of magnitude lower than infection mediated by virion-
incorporated gD.
Soluble gD-mediated entry of gD-deficient HSV requires
specific interaction with a membrane-bound gD receptor
Productive HSV-1 entry into cells depends on the interaction
of virion gD with a cognate receptor. To confirm that the
observed entry of gD-deficient virus required a similar
interaction and was not mediated by contaminants in our sgD
preparations, we tested receptor-specific versions of the soluble
protein. The L25P mutation in gD impairs virus entry through
HVEM without diminishing entry via nectin-1 (Yoon et al.,
2003). In addition, we previously isolated a rare gD mutant with
the reciprocal properties [gD(R222N,F223I); Q. Bai, W. Ali
Shah, J.B. Cohen, R.J. Eisenberg, G.H. Cohen and J.C.
Glorioso. Abstr. 26th International Herpesvirus Workshop,
abstr. 2.10, 2001]; the characteristics of this mutant have been
confirmed and described in more detail by others (Manoj et al.,
2004). As shown in Fig. 1C, sgD287(L25P) displayed a
substantially reduced ability to mediate entry into CHO-
HVEM cells (compare panels 3 and 5) while its ability to
mediate entry into CHO-nectin-1 cells was unaltered compared
to wild-type sgD287 (panels 4 and 6). Conversely, sgD287
(R222N,F223I) mediated entry into CHO-HVEM, but not
CHO-nectin-1 cells (panels 7 and 8). These results showed that
sgD-mediated entry of gD-deficient virus required specific
receptor recognition in a manner similar to infection by
complete virions; they argued strongly against the possibility
that entry was mediated by an unrelated contaminant in our sgD
preparations.
Establishment of parameters for sgD-mediated entry
By analogy to current models for gD+ virus entry, we
hypothesized that sgD binding to its receptor enabled a
subsequent interaction between the soluble molecule and the
viral envelope that initiated membrane fusion to deliver de-
enveloped particles to the cytoplasm. To test this prediction,
CHO-HVEM cells were incubated with sgD for 1 h at 37 °C,
washed several times to remove unbound sgD, and exposed to
gD-deficient KΔUs3-8Z at 37 °C. The results, summarized in
Table 1, showed that infection was reduced to background
levels under these conditions (Table 1 protocol 3 and Fig. 2C),
compared to readily detectable infection when sgD and the
virus were added to the cells either simultaneously (Table 1
protocol 1 and Fig. 2B) or in the reverse order (Table 1
protocol 2 and Fig. 2D). Negligible infection was also
observed when sgD was bound to the cells at 4 °C prior to
the washes, and the virus was added at 37 °C (Table 1 protocol4). However, when sgD binding at 4 °C was followed by virus
binding at 4 °C and a second washing step before the
temperature was raised, infection occurred (Table 1 protocol 5).
These results suggested that the virus must interact with
receptor-bound sgD prior to entry and that the enabling activity
of sgD is unstable.
Additional experiments showed that the loss of sgD activity
under the conditions of protocols 3 and 4 (Table 1) could be
attributed to sgD dissociation from the cells at 37 °C. First, the
levels of cell-associated sgD before and after incubation at 37 °C
were compared by immunofluorescence. The cells were
incubated with sgD for 2 h at 4 °C, washed, and fixed either
immediately or after incubation at 37 °C for 30 min in fresh
medium. Staining with a pool of gD-specific monoclonal
antibodies (Highlander et al., 1987) showed abundant cell-
associated sgD before, but not after the 37 °C incubation
period for both CHO-HVEM (Figs. 3A, B) and CHO-nectin-1
cells (Figs. 3C, D). Second, the amount of CHO-HVEM-
associated sgD before and after incubation for 10 or 30 min at
37 °C was determined by immunoblotting. Samples were
prepared by incubation of the cells with sgD for 2 h at 4 °C,
followed by several washes, incubation at 37 °C, and
collection of cell lysates. This analysis, as well, showed a
loss of cell-associated sgD over time (Fig. 4A, lanes 2–4). In
a separate experiment, we collected both the cells and the
medium after the 30-min incubation period at 37 °C and
compared the total amount of sgD in both samples with the
amount of cell-associated sgD at the start of the 37 °C
incubation. The results showed that the entire amount of sgD
associated with the cells at time zero could be recovered from
the medium at the end of the 37 °C incubation period (Fig.
4B). Consistent with this result, we found that all cell-
associated sgD at the different time points were sensitive to
treatment of the cells with trypsin prior to cell lysis (Fig. 4A,
lanes 5–7), supporting the conclusion that the loss of sgD
from the cell surface at 37 °C was due to dissociation rather
than internalization by the cells.
Additional Western blot analyses demonstrated that sgD was
not stabilized at the cell surface by prior virus attachment and
that all cell-associated sgD detected under these conditions
before or after incubation at 37 °C remained fully sensitive to
trypsin (Fig. 4C). These observations argued that cell-associated
virus and sgD did not engage in a stable interaction at 37 °C and
that sgD was not endocytosed in the presence of virus. Instead,
they suggested that sgD interacts transiently with the virus prior
to virus entry.
Fig. 2. Pre-attachment of sgD to CHO-HVEM cells eliminates efficient infection
by gD− KΔUs3-8Z. Cells were incubated with (A) gD− KΔUs3-8Z at 37 °C for
3 h, (B) gD− KΔUs3-8Z plus sgD for 3 h at 37 °C, (C) sgD at 37 °C for 1 h,
washed, and then incubated with gD− KΔUS3-8Z for 3 h or (D) gD− KΔUs3-8Z
at 37 °C for 1 h, washed, and then incubated with sgD for 3 h. Media were
replaced with fresh medium and infected cells identified by X-gal staining 16 h
later.
Fig. 3. Detection of cell-associated sgD. sgD was bound to CHO-HVEM (A and
B) or CHO-nectin-1 (C and D) cells at 4 °C for 2 h. Cells were washed and either
fixed immediately (A and C) or the temperature was shifted to 37 °C for 30 min
prior to fixation (B and D). Cell-associated sgD was detected with a pool of
monoclonal anti-gD antibodies and a goat anti-mouse secondary antibody linked
to Cy3.
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infection of susceptible CHO cells occurs by pH-dependent
endocytosis and requires intra-endosomal interaction of the
virus with a gD receptor (Nicola et al., 2003; Nicola and Straus,
2004). Our evidence that sgD interacts transiently with gD-
deficient virus at the cell surface to mediate virus entry, but is
not itself internalized, argued against sgD mediating virus
release from endosomes. Accordingly, we asked whether
productive sgD-mediated infection of CHO cells requires the
preceding step in endocytosis, endosome acidification. CHO-
HVEM and CHO-nectin-1 cells were treated with bafilomycin
A1, a specific inhibitor of vacuolar H+-ATPase, for 30 min and
infected in the continued presence of the drug for 5.5 h. For
comparison, we used a replication-defective vesicular stomatitis
virus (VSV) recombinant that expresses green fluorescent
protein (GFP) (Bergman et al., 2003) and recorded GFP
expression at 4 h post-infection, prior to widespread VSV-
mediated cell death. As illustrated in Fig. 5 (second column),
treatment of the cells with bafilomycin did not reduce
productive sgD-mediated infection. Surprisingly, the drug also
failed to inhibit infection by gD-complemented KΔUs3-8Z
(Fig. 5, third column) or an ICP4-deleted KOS derivative
(SHZ.1, fourth column) (Mester et al., 1995) whereas infection
by VSV-GFP was completely abolished (fifth column).
Although we used a higher concentration of bafilomycin
(400 nM) than is common in the literature (≤200 nM; Akula
et al., 2003; Bergman et al., 2003; Gianni et al., 2004; Milne et
al., 2005; Nicola et al., 2003; Nicola and Straus, 2004), weobserved no clear changes in cell survival or morphology in
mock-infected cultures treated with the drug (e.g. Fig. 5, first
column). These results indicated that productive infection by
gD-deficient HSV through either complementation or sgD did
not require exposure to a low-pH environment. Although we
have no direct evidence demonstrating the specific virus entry
pathway, our combined results favor the suggestion that sgD-
mediated productive infection occurs by fusion at the cell
surface rather than by endocytosis.
Conformational stability of receptor-bound sgD
In our Western blot analysis of the fate of cell-bound sgD at
37 °C (Fig. 4A), a trypsin-sensitive signal was still detectable at
the 10-min time point. We asked whether this material retained
the ability to mediate gD-deficient virus entry. As outlined in
Fig. 6A, we bound sgD to the cells at 4 °C, washed the cells,
raised the temperature to 37 °C for 0–30 min, and then chilled
the cells, added gD-deficient KΔUs3-8Z for a 2-h incubation
at 4 °C, washed the cells again, and brought the temperature
back to 37 °C for a 3-h infection period. The results (Fig. 6B)
showed a gradual decline in infection with progressively longer
incubation times at 37 °C prior to virus binding. This gradual
decrease appeared comparable to the rate of sgD dissociation
from the cells observed under the same conditions (Fig. 4A),
suggesting that the entry-mediating conformation of sgD is
stable as long as the soluble molecule remains bound to the cells.
sgD-mediated entry into glycosaminoglycan (GAG)-deficient
cells
Since gD-deficient HSV lacks the ability to interact with gD
receptors, we expected that sgD-mediated entry would be
Fig. 4. sgD localization by Western blot analysis with R7 anti-gD antibody. (A) sgD or no protein was bound to CHO-HVEM cells for 2 h at 4 °C. Cells were washed
with cold PBS and either lysed immediately (lanes 1 and 2) or incubated with fresh, pre-warmed media at 37 °C for 10 min (lane 3) or 30 min (lane 4). To identify
internalized sgD, duplicate cultures were treated with trypsin prior to cell lysis (lanes 5–7). (B) sgD was bound to CHO-HVEM cells for 2 h at 4 °C. The cells were
washed and lysed either immediately (lane 1) or after incubation at 37 °C for 30 min with fresh, pre-warmed media (lane 2). The media was collected at the end of the
37 °C incubation and the protein contents precipitated with TCA (lane 3). (C) sgD and gD− KΔUs3-8Z were bound to CHO-HVEM cells for 2 h at 4 °C. Cells were
washed with cold PBS and either lysed immediately (lane 1) or incubated with fresh, pre-warmed media at 37 °C for 10 min (lane 2) or 30 min (lane 3). For
identification of internalized sgD, duplicate cultures were treated with trypsin prior to cell lysis (lanes 4–6).
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To test this prediction, we generated a GAG-deficient, nectin-1-
expressing cell line (pgsA745-nectin-1) by stable transfection of
a selectable nectin-1 expression plasmid (Takahashi et al., 1999)
into CHO mutant cells (pgsA745) that are defective in GAG
synthesis (Esko et al., 1985). Characterization of the new line by
flow cytometry for nectin-1 expression and by X-gal staining
for susceptibility to gD+ virus infection is presented in Fig. 7.
These analyses showed that the fraction of cells expressing cell-
surface nectin-1 was much greater for the pgsA745-nectin-1
line (Fig. 7B) than for the GAG-expressing CHO-nectin-1 line
used in our earlier experiments (Fig. 7A). Furthermore,
pgsA745-nectin-1 cells expressed more surface nectin-1 per
cell than their CHO-nectin-1 counterparts. Nevertheless, the
GAG+ CHO-nectin-1 line was more susceptible to HSV-1
infection, as illustrated using KHZ.1, a recombinant KOS virus
that expresses lacZ (Mester et al., 1995; Rasty et al., 1995)
(Figs. 7C and D). These characteristics may suggest that GAGs
lower the threshold level of nectin-1 required for cellular
susceptibility to HSV-1, consistent with previous observations
that GAGs increase the efficiency of infection (Banfield et al.,
1995; Gruenheid et al., 1993; Herold et al., 1991, 1994;
Laquerre et al., 1998; Shieh and Spear, 1994). In addition, high
levels of nectin-1 may not translate into greater receptor
availability for viral gD as an increased abundance of nectin-1
may be expected to favor the formation of cell junctions.
Sequestration of nectin-1 in cell junctions is known to reduce
virus infection (Yoon and Spear, 2002).
Remarkably, we observed that the pgsA745-nectin-1 line was
permissive for sgD-mediated infection by gD-deficient KΔUs3-
8Z despite the absence in this system of established mechanisms
for virus attachment (Figs. 8C and D). Moreover, infection was
typically more widespread on pgsA745-nectin-1 cells than on the
GAG-expressing CHO-nectin-1 line (compare Figs. 8D and F).One possible explanation for these observations is the broader
expression of nectin-1 on pgsA745-nectin-1 cells, suggesting that
the rate-limiting step in sgD-mediated entry is not virus
attachment, as in gD+ virus entry, but a nectin-1-dependent
event, such as the establishment of an interaction between nectin-
1-bound sgD and the virus. Alternatively, if the availability of
nectin-1 on pgsA-nectin-1 cells is limited due to widespread
formation of cell junctions, sgD may invade and disrupt these
junctions more readily than complete gD+ virus particles, thus
explaining the observation that nectin-1 levels correlate with
productive entry in sgD-mediated, but not gD+ virus infection.
Indeed, Krummenacher and colleagues have reported that a
soluble gD similar to ours [gD(285t)] efficiently disrupts nectin-1-
dependent aggregation of B78H1-C10 cells, whereas wild-type
virus (HSV-1 KOS) or a soluble gD that has lower affinity for
nectin-1 [gD(306t)] does not (Krummenacher et al., 2002).
Binding of gD-deficient virus to GAG-deficient cells
The unexpected finding of virus entry in the absence of
GAGs and virion gD, along with the suggestion that virus
attachment is not rate-limiting in sgD-mediated infection,
indicated that HSV-1 may have a GAG- and gD-independent
means of binding to cells. To examine this possibility, we
incubated pgsA745-nectin-1 cells with gD-deficient KΔUs3-8Z
for 2 h at 4 °C, washed the cells to remove unbound virus, and
lysed the cells for detection of cell-associated viral protein.
Western blot analysis showed that the lysate contained the major
capsid protein VP5 (Fig. 9A, lane 3), supporting the existence of
a previously unknown binding interaction between the virus and
cells. The VP5 signal was not increased by the presence of sgD
during the binding step (Fig. 9A, lane 2), indicating that sgD
interaction with its receptor did not significantly contribute to
virus binding at 4 °C.
Fig. 5. Sensitivity of viral reporter gene expression to bafilomycin A1 (BafA) treatment of the cells. CHO-HVEM and CHO-nectin-1 cells were incubated for 30 min at 37 °C in medium with or without 400 nM BafA.
The cells were infected with gD-deficient KΔUs3-8Z alone or in the presence of 500 ng sgD. Control infections were performed with gD-complemented KΔUs3-8Z, replication-deficient SHZ.1, or VSV-GFP. After 4 h
in the continued presence or absence of BafA, VSV-infected cells were photographed under a fluorescent microscope. HSV-exposed cultures were incubated for 5.5 h in the continued presence or absence of the drug and
stained with X-gal 24 h later.
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Fig. 6. sgD retains its ability to mediate entry of gD-deficient KΔUs3-8Z while cell-associated. (A) Sequential incubation protocol. (B) Infected cells identified by
X-gal staining.
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infection by gD+ virus (KHZ.1) and sgD-mediated infection
by gD− virus, we compared the binding of both viruses to GAG+
and GAG− cells. As shown in Fig. 9B, GAGs enhanced the
binding of gD− KΔUs3-8Z to both nectin-1-bearing cells (lanes
3 and 4) and nectin-1-deficient cells (lanes 1 and 2). Since sgD-
mediated infection was not increased by the presence of GAGs
(Fig. 8), these results supported the earlier suggestion that virus
attachment is not a limiting step in sgD-mediated entry. As
expected, nectin-1 expression had no detectable effect on the
binding of gD− KΔUs3-8Z (Fig. 9B, lanes 2 and 3),
demonstrating that the interaction of this virus with pgsA745-
nectin-1 cells did not involve nectin-1 and thus could not be
attributed to residual envelope gD in the virus preparation or to
previously unknown interactions of nectin-1 with other envelope
components. The results for KHZ.1 showed GAG- and gD
receptor-independent binding as well (Fig. 9C, lane 2),
indicating that both gD− and gD+ virus possess a cell attachment
mechanism that requires neither cell surface GAGs nor a gD-
receptor interaction. As expected, KHZ.1 binding to both nectin-
1-bearing and nectin-1-deficient cells was greatly augmented byGAGs (Fig. 9C, lanes 4 and 1). We used this enhancement to
confirm the GAG- and gD-independent interaction. Thus, we
found that the binding of KHZ.1 to CHO-K1 cells was reduced
to the level observed for KHZ.1 binding to pgsA745 cells by pre-
treatment of the cells with a mixture of heparinases I and III,
whereas the binding of KHZ.1 to pgsA745 cells was resistant to
the same pre-treatment (data not shown). This control experi-
ment showed that KHZ.1 binding to pgsA745 cells was not due
to residual GAGs on the GAG-deficient cells. KHZ.1 attachment
to pgsA745 cells was detectably enhanced by nectin-1 (Fig. 9C,
lane 3), providing direct evidence that nectin-1 can function as
an attachment receptor for gD+ virus, at least in the absence of
GAGs. Together, these results supported the suggestion that
virus attachment is rate-limiting for gD+ virus infection, but not
for sgD-mediated infection, and that virus attachment in sgD-
mediated infection occurs by a novel binding interaction.
Discussion
HSV infection involves several stages consisting of attach-
ment, initiation of fusion of the virus envelope with the cell-
Fig. 7. Nectin-1 expression on CHO-nectin-1 and pgsA745-nectin-1 cells and susceptibility of both lines to lacZ-expressing HSV-1 KOS recombinant KHZ.1. (A)
CHO-nectin-1 or (B) pgsA745-nectin-1 cells were incubated with CK41 monoclonal antibody for 1 h at 4 °C followed by incubation with anti-mouse FITC-conjugated
antibody for 30 min. Cells were fixed and receptor levels on each cell line were quantitated by flow cytometry. (C) CHO-nectin-1 or (D) pgsA745-nectin-1 cells were
infected with KHZ.1 (MOI=1) for 2 h at 37 °C and X-gal stained at 16 h post-infection.
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reaction with release of de-enveloped particles into the
cytoplasm. Virus attachment is mediated by the binding of
viral envelope components gB and gC to glycosaminoglycan
moieties (GAGs) at the cell surface with subsequent or
simultaneous binding of viral envelope gD to one of several
possible cell-surface co-receptors, including HVEM, nectin-1,
or 3-OST-3 modified heparan sulfate (Banfield et al., 1995;Fig. 8. sgD-mediated infection of receptor-bearing CHO-K1 cells by gD-deficient HS
nectin-1 (GAG−), and CHO-nectin-1 (GAG+) cells were infected with gD-deficient K
was visualized 16 h later by X-gal staining.Geraghty et al., 1998; Laquerre et al., 1998; Montgomery et al.,
1996; Shieh et al., 1992; Shukla et al., 1999). Engagement of a
gD receptor is thought to provide a signal to the fusion apparatus
launching the fusion cascade. In this model, gD does not play a
direct role in the fusion mechanism. Rather, the fusion apparatus
most likely consists of the envelope components gB and gH
since deletion of either glycoprotein blocks fusion, but not virus
attachment (Cai et al., 1987, 1988; Forrester et al., 1992; Roop etV-1 is not dependent on the presence of cell-surface GAGs. pgsA745, pgsA745-
ΔUs3-8Z in the presence (B, D, F) or absence (A, C, E) of sgD287. Virus entry
Fig. 9. gD− KΔUs3-8Z attachment to GAG-deficient cells. (A) pgsA745-nectin-
1 cells were mock treated (lane 1) or incubated with gD− KΔUs3-8Z and sgD
(lane 2) or KΔUs3-8Z alone (lane 3) for 2 h at 4 °C. Cells were washed, lysed,
and analyzed by Western blot using anti-HSV-1 VP5 antibody. A prominent,
non-specific cellular band is shown as a loading control. (B, C) CHO-K1 (lanes
1), pgsA745 (lanes 2), pgsA745-nectin-1 (lanes 3), and CHO-nectin-1 cells
(lanes 4) were incubated with gD− KΔUs3-8Z (B) or KHZ.1 (C) for 2 h at 4 °C.
Cells were washed to remove unbound virus, lysed, and the total cell lysate
analyzed by Western blot using anti-VP5 antibody. β-actin was visualized as a
loading control.
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active fusion domain (Gianni et al., 2005a,2005b, 2006). We
sought to develop an experimental approach whereby gD
engagement of its receptor provides an activating signal to the
fusion machinery in trans. This approach was intended to clarify
the order of events leading to fusion and allow examination of
the role of GAGs in the absence of virus attachment to the cells
through gD-receptor interactions.
We previously demonstrated that a soluble, gD-binding
domain of nectin-1 was capable of efficient induction of entry
provided that the virus was bound to the cells via GAGs. These
experiments supported the conclusion that engagement of a gD
receptor was sufficient to initiate envelope fusion, arguing
against the need for a receptor-transduced signal through the
target membrane (Kwon et al., 2006). In the current study, we
asked whether soluble gD interacting with HVEM or nectin-1
expressed on the cell surface could promote entry of virions that
lack gD. While this proved to be the case, others reported a
similar observation (Cocchi et al., 2004), leading us to address
aspects of the process that were not examined in the published
study. These included the efficiency, receptor dependence, and
receptor specificity of sgD-mediated infection. In addition, we
sought to gain a better understanding of the steps involved in this
mode of entry. Our results showed that sgD-mediated entry
depends on sgD binding to HSV entry receptors with a
specificity similar to that of virion gD binding. Although sgD-
mediated entry was less efficient than virus entry mediated byvirion gD, this reduction was most likely caused by the slower
assembly of fusion-initiating complexes from three separate
components (cells, gD− virus and sgD) rather than two (cells and
gD+ virus). These observations supported the conclusion that
sgD engagement of its receptor resulted in signaling to the fusion
apparatus in a manner similar to that occurring in natural
infection. However, two surprising observations were made
during the course of this study. First, GAGs on the cell surface
did not increase the efficiency of sgD-mediated infection of gD-
deficient virus, indicating that entry occurred independently of
virus binding to GAGs. Second, gD-deficient virus was capable
of attaching to GAG-deficient cells, suggesting that virus
binding occurred via an unknown receptor in a manner that
involved neither gD nor GAGs.
In experiments to define the temporal order of the initial
interactions required for sgD-mediated virus entry, we sought
to determine whether sgD binding to HVEM or nectin-1
created a stable receptor complex for gD-deficient virus entry.
We observed that sequential incubation of the cells with sgD
and virus, separated by a washing step to remove free sgD,
resulted in entry only when both steps were completed before
the temperature was raised. Subsequent studies showed that
sgD dissociated from the cells at 37 °C in the absence of
abundant sgD in the medium, suggesting that virus added to
sgD-coated cells at 37 °C did not diffuse rapidly enough to
the cell surface to engage sgD prior to dissociation of the
soluble molecule from its receptor. This interpretation implied
that sgD-mediated infection requires the simultaneous pre-
sence of virus and sgD at the cell surface, as also proposed
by Cocchi et al. (2004), suggesting that the intact sgD-
receptor complex serves as an entry receptor for gD-deficient
HSV.
We considered the possibility that the dependence of sgD-
mediated entry on the simultaneous presence of virus and sgD at
the cell surface could additionally reflect instability of the entry-
mediating conformation of receptor-bound sgD at 37 °C,
causing inactivation of the intact sgD-receptor complex; such
instability could prevent productive interaction with newly
added virus even before sgD dissociation occurred. Experiments
to examine this possibility showed that incubation of cell-bound
sgD for 15 min at 37 °C in sgD- and virus-free medium did not
abolish entry of subsequently added gD− virus. Although entry
was reduced due to sgD dissociation, the remaining activity
indicated that the active conformation of sgD is stable as long as
the soluble molecule remains bound to its receptor. Thus, we
propose that receptor binding converts sgD to an active
conformation at 37 °C that persists until the complex dissociates
or sgD interacts with virus to initiate the entry cascade.
The use of CHO cells in our experiments clearly
demonstrated that cells other than those examined by Cocchi
and colleagues are susceptible to sgD-mediated infection.
Several reports have demonstrated that infection of CHO cells
occurs by an endocytic pathway (Milne et al., 2005; Nicola et
al., 2003; Nicola and Straus, 2004), whereas the different
lines used in the study of Cocchi et al. undergo infection by
fusion at the cell surface (Cocchi et al., 2004). In our study,
sgD was not stably bound to its cognate receptor and the
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surface at 37 °C. While the virus was able to utilize receptor-
bound sgD for entry, infection did not appear to be
accompanied by sgD internalization. These results indicated
that receptor-bound sgD interacted transiently with the virus
and did not function as a receptor for stable virus attachment
to the cells. Furthermore, they suggested that sgD did not act
intracellularly to mediate receptor-dependent virus release
from endosomes. We observed no inhibition of productive
infection by bafilomycin A1, suggesting that capsid transport
to the nucleus did not require virus exposure to an acidic pH.
In combination, these results are most consistent with the
possibility that sgD-mediated productive infection does not
occur by endocytosis, but instead takes place by envelope
fusion with the cytoplasmic membrane. We have initiated
additional studies to strengthen this conclusion and better
understand apparent inconsistencies with previous reports.
First, it is possible that our trypsin protection assay was not
sensitive enough to detect small amounts of internalized sgD
that could be sufficient to trigger capsid exit from endosomes.
Second, Nicola and colleagues showed that productive
infection of receptor-bearing CHO cells by gD+ HSV-1 is
sensitive to various lysosomotropic agents (Nicola et al.,
2003). Our finding that CHO cell infection by gD-
complemented KΔUs3-8Z is resistant to a relatively high
concentration of bafilomycin raised the question whether this
mutant virus behaves in an atypical manner. However,
preliminary results in our laboratory indicate that other
HSV-1 recombinants may also be resistant to the drug (e.g.
SHZ.1, Fig. 5). While Nicola and colleagues did not report
the effect of bafilomycin on viral reporter gene expression or
other indicators of productive infection, they did provide
visual and biological evidence that this drug, considered one
of the most specific lysosomotropic agents available, blocked
the delivery of capsids to the nuclei of permissive CHO cells
(Nicola et al., 2003: Nicola and Straus, 2004). It is
conceivable, although not predictable, that the outcome of
their microscopy experiments was influenced by the cyclo-
heximide treatment included during infection (Nicola et al.,
2003). It is also noteworthy that HSV infection of B78-C10
cells reportedly involves a bafilomycin-resistant endocytic
pathway (Milne et al., 2005).
Analogous to normal HSV infection, it was anticipated that
sgD-mediated infection would be enhanced by virus binding to
cell-surface GAGs. In support of this prediction, we previously
reported that GAGs are required for efficient HSV infection of
gD receptor-deficient CHO cells mediated by a soluble form of
nectin-1 or a soluble, bispecific adapter (Kwon et al., 2006;
Nakano et al., 2005). Surprisingly, we observed that GAG-
deficient CHO-K1 cells expressing nectin-1 were at least as
susceptible to sgD-mediated infection as GAG-bearing CHO-
nectin-1 cells. By comparing the amounts of gD-deficient virus
bound to pgsA745-nectin-1 cells in the absence and presence of
sgD, we obtained evidence for GAG- and sgD-independent
virus attachment, suggesting the existence of a previously
unknown attachment mechanism. Since the gD-deficient virus
used in these experiments also lacked gG, gJ, gI, and gE, wecould rule out a role for these glycoproteins in the proposed
novel attachment process. We also found that a gD+ virus could
bind to receptor-deficient pgsA745 cells and that this binding
was resistant to pre-treatment of the cells with heparinases.
In a recent report, Bender and co-workers described
heparin-resistant binding of a soluble gB ectodomain to cells,
along with blocking of this interaction by virus-neutralizing
anti-gB monoclonal antibodies and reduced infection of
heparan sulfate-deficient cells in the presence of soluble gB
(Bender et al., 2005). These results suggested a novel binding
interaction between gB and target cells that plays a role in
entry. It seems likely that this is the same interaction we report.
While we show that both gD+ and gD− virus can bind to GAG-
deficient cells that lack entry receptors (Fig. 9), we noticed a
difference between the two viruses when their binding to
GAG-deficient cells (Figs. 9B and C, lane 2) was normalized
to their binding to GAG+ cells (Figs. 9B and C, lane 1). This
observation raises the possibility that virion gD controls the
novel binding interaction, blocking it until gD changes
conformation by binding to a receptor. In this manner, gD
might ensure orderly interaction of gB with GAGs and the
predicted novel gB receptor, keeping the attachment and entry
processes separate. Since gD-deficient virus is not infectious
for GAG-deficient cells, it is nevertheless clear that the novel
interaction is not sufficient for entry and that gD carries out
functions besides controlling this interaction.
In conclusion, the combination of gD-deficient virus, GAG-
deficient cells, and entry triggered by the addition of sgD should
facilitate further characterization of the complex roles of gD and
other envelope glycoproteins in the different pathways utilized
by HSV to gain entry into cells. While it remains to be
established whether sgD faithfully mimics the activities of
envelope-embedded gD in these different situations, the
availability of a trans-acting system that is operational across
multiple types of host cells (Cocchi et al., 2004, and this work)
adds a new dimension to the study of the initial events leading to
HSV infection.
Materials and methods
Cells and viruses
Vero and 293T cells were obtained from the ATCC. VD60, a
gD-complementing cell line (Ligas and Johnson, 1988), was a
gift from Dr. David C. Johnson (Oregon Health Sciences
University). Vero, VD60, and 293T cells were grown in
Dulbecco's modified Eagle's medium (DMEM; Invitrogen,
Carlsbad, CA) supplemented with 5% fetal bovine serum
(FBS). Chinese hamster ovary cells (CHO-K1) and CHO-K1
cells stably expressing HVEM or nectin-1 were kindly provided
by Dr. Patricia Spear (Northwestern University) and grown in F-
12K medium (Invitrogen) supplemented with 10% FBS.
pgsA745 cells (Esko et al., 1985) were obtained from ATCC
(CRL-2242). pgsA745-nectin-1 cells were derived from
pgsA745 cells by transfection with a full-length nectin-1
cDNA expression plasmid (Takahashi et al., 1999) and cloning
of hygromycin B-resistant cells.
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virus contains a lacZ reporter gene under transcriptional
control of a human cytomegalovirus (HCMV) promoter in
place of the unique short (US) region 3 through 8 genes of the
HSV-1 genome, including the glycoprotein D (Us6) gene
(Anderson et al., 2000). KΔUs3-8Z was propagated and titered
on VD60 cells and passaged through Vero cells to obtain gD-
deficient virions. KHZ.1 is a KOS-derived virus containing an
HCMV-lacZ expression cassette in the thymidine kinase locus
(Mester et al., 1995; Rasty et al., 1995). SHZ.1, which is isogenic
with KHZ.1 except for the deletion of both copies of the ICP4
gene (Mester et al., 1995), was propagated on ICP4-comple-
menting E5 cells (DeLuca et al., 1985). VSV-EGFP-δG coated
with VSV-G protein (Bergman et al., 2003) was kindly
provided by Dr. Patricia Whitaker-Dowling (University of
Pittsburgh).
Construction of sgD plasmids
The HSV-1 SacI fragment containing the gD promoter and
coding sequence was cloned into pSP72 (Promega, Madison,
WI) and the resulting plasmid designated pgDSac. The
transmembrane region of gD was removed after amino acid
287 by digesting pgDSac with NarI and EcoRI and replacement
of the excised fragment with annealed complementary oligo-
nucleotides specifying 6 histidine residues followed by a stop
codon (primer 1: 5′ CG CAC CAT CAC CAT CAC CAT TAG
TTT AAA CGG GGG 3′; primer 2: 5′ A ATT CCC CCG TTT
AAA CTA ATG GTG ATG GTG ATG GTG 3′). The truncated
gD-His6 sequence was isolated from a selected recombinant by
digestion with HindIII and EcoRI and placed under transcrip-
tional control of the HCMV promoter in expression vector
pcDNA3.1+ (Invitrogen). The resulting plasmid, psgD287, was
confirmed by DNA sequencing.
Mutant sgD constructs were obtained by transfer of
appropriate regions from pgDSac mutant constructs. The
L25P mutation was introduced into pgDSac using the Gene
Editor in vitro site-directed mutagenesis kit (Promega). The
R222N,F223I double mutation was obtained by cloning a
degenerate oligonucleotide between codon 221 and 230 of
pgDSac, screening of recombinant plasmids for complementa-
tion of gD-deficient KΔUs3-8Z entry into CHO-HVEM, but
not CHO-nectin-1 cells, and sequencing of selected constructs
(W.A.S., J.B.C., and J.C.G., unpublished results). In order to
transfer the L25P and R222N,F223I mutations from pgDSac to
psgD287, an acceptor plasmid (psgD287Δ) was first derived from
psgD287 by deletion of an internal 216-bp BstZ17I–NaeI
fragment. The desired mutations were then transferred from
the pgDSac-based plasmids as HindIII–PpuMI fragments,
restoring the deleted region in the acceptor plasmid. Recombi-
nants were identified by digestion with FspI, which cuts in the
deleted region and distinguishes between pgDSac and psgD287.
Purification of sgD proteins
293T cells were transfected with psgD287, psgD287(L25P), or
psgD287(R222N,F223I) plasmids using LipofectAMINE-Plus(Invitrogen). Twenty-four hours post-transfection, medium was
replaced with serum-free medium. Two days later, supernatants
were collected and loaded onto ProBond (Invitrogen) nickel-
chelating columns for purification of the His-tagged proteins
according to the manufacturer's protocol. Proteins were
concentrated using a Centricon YM-10 centrifugal filter device
(Amicon, Bedford, MA) and dialyzed against PBS at 4 °C
overnight. The purity and molecular weight of each protein
were estimated by Western blot analysis using polyclonal anti-
gD antibody R7 (kindly provided by Drs. G.H. Cohen and R.J.
Eisenberg, University of Pennsylvania) and an anti-rabbit HRP-
conjugated secondary antibody (Santa Cruz Biotechnology,
Santa Cruz, CA), or using an anti-His HRP-conjugated antibody
(Invitrogen). Protein concentrations were determined by
Bradford assay (Bio-Rad, Hercules, CA).
sgD287-mediated infection of CHO-K1-derived cells by
KΔUs3-8Z
CHO-K1, CHO-HVEM, CHO-nectin-1, pgsA745, and
pgsA745-nectin-1 cells were plated in 96-well plates at
5×104 cells/well. Subconfluent monolayers were incubated
with gD-deficient KΔUs3-8Z in the presence of 500 ng sgD287,
sgD287(L25P), or sgD287(R222N,F223I) for various times at
4 °C or 37 °C. The monolayers were then washed, overlaid
with F-12K/10% FBS medium, and incubated at 37 °C. After
16 h, β-galactosidase activity was visualized by X-gal staining
(Research Products International Corp., Mt. Prospect, IL). Over
the course of this work, different preparations of gD-deficient
KΔUs3-8Z virus were used. The activities of these prepara-
tions were standardized as transducing units/ml, measured as
the number of blue cells per unit volume induced on CHO-
HVEM cells in the presence of sgD.
Bafilomycin inhibition
2×104 CHO-HVEM or CHO-nectin-1 cells were seeded in a
96-well plate. The following day, the cells were washed once
with medium and incubated for 30 min at 37 °C with fresh
medium alone or medium containing 400 nM bafilomycin A1
(Sigma, St. Louis, MO). The cells were then infected in the
continued presence or absence of the drug with (i) gD-deficient
KΔUs3-8Z with or without 500 ng sgD; (ii) gD-complemented
(gD+) KΔUs3-8Z; (iii) SHZ.1; or (iv) VSV-GFP, the last three
at an MOI of 5 determined on Vero cells. GFP expression in
VSV-infected cultures was visualized at 4 h post-infection using
a fluorescent microscope. HSV-infected cultures were washed
at 5.5 h post-infection, incubated for an additional 24 h in fresh
medium, and stained with X-gal.
Detection of cell-bound sgD by immunofluorescence
Subconfluent monolayers of CHO-HVEM or CHO-nectin-1
cells in a 48-well plate were incubated with 1 μg of sgD for 2 h
at 4 °C. The cells were then washed and either fixed
immediately with 2% paraformaldehyde or the temperature
was raised to 37 °C for 30 min before fixation. The fixed cells
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antibodies (Highlander et al., 1987) at a 1:5000 dilution for 1 h
at room temperature (RT). The cells were then washed again,
incubated for 1 h with a 1:500 diluted, Cy3-conjugated anti-
mouse secondary antibody (Sigma), and visualized at 200×
magnification under a Nikon Diaphot TMS fluorescent
microscope (Nikon, Melville, NY). Photographs were taken
with a Leica Microsystems AG DFC 300F digital camera
(Leica, Deerfield, IL).
Flow cytometry
Mouse monoclonal antibody CK41 (Krummenacher et al.,
2000) at a 1:250 dilution was used to identify surface nectin-1 in
adherent cell cultures. Antibody binding and washes were
performed at 4 °C in PBS containing 1% horse serum
(Invitrogen). Cell bound CK41 was detected using FITC-
conjugated anti-mouse antibody (Sigma) and analyzed on a
FACSCalibur (Becton-Dickinson, San Diego, CA).
Detection of cell-bound virus by Western blot analysis
Virus (KHZ.1 at an MOI of 100 or gD-deficient KΔUs3-8Z
at approximately 0.7 transducing units/cell) was adsorbed to
confluent monolayers of CHO-HVEM, CHO-nectin-1,
pgsA745, pgsA745-nectin-1, or CHO-K1 cells in a 24-well
plate for 2 h at 4 °C, either in the presence or absence of 1 μg
sgD. The cells were then washed with cold buffer and lysed
with 50 μl PARP buffer (6 M urea, 2% SDS, 10% glycerol,
62.5 mM Tris–HCl, pH 6.8, and 5% β-mercaptoethanol) (Pink
et al., 2000). Each sample was sonicated for 20 s with a Fisher
Scientific 60 Sonic Dismembrator (Fisher Scientific, Hampton,
NH). Unless indicated otherwise, half of each lysate was
electrophoresed on a 10% SDS-polyacrylamide gel and the
proteins were transferred to an Immobilon PVDF membrane
(Millipore, Billerica, MA). The membrane was blocked for 1 h
in 5% non-fat dry milk (NFDM) in PBS–Tween (PBST) at RT
and reacted with NC1 polyclonal rabbit anti-VP5 antiserum
(kindly provided by Dr. Fred Homa, University of Pittsburgh) at
a 1:5000 dilution in 5% NFDM/PBST at RT for 1.5 h. The
membrane was washed, incubated with HRP-conjugated goat
anti-rabbit secondary antibody (Santa Cruz Biotechnology) at a
1:2000 dilution, and developed using an Amersham ECL kit
(Amersham, Buckinghamshire, England). As a control for the
amount of protein loaded in each lane, the membrane was re-
probed with a mouse anti-actin monoclonal antibody (Chemi-
con International, Temecula, CA) at a 1:5000 dilution.
Trypsin sensitivity assay
Confluent monolayers of CHO-HVEM cells in a 24-well
plate were incubated with 1 μg sgD/well for 2 h at 4 °C in the
presence or absence of gD-deficient KΔUs3-8Z (∼0.7 transdu-
cing units/cell). Cells were washed with ice-cold PBS and lysed
in PARP buffer either immediately or after 10–30 min
incubation at 37 °C in fresh medium; supernatants were
collected at the 10 and 30 min time points prior to lysis andthe protein contents precipitated at 4 °C with 10% TCA.
Duplicate samples were treated with 100 μg/ml TPCK-trypsin
(Sigma) for 2.5 min prior to lysis. Trypsin was quenched with
200 μg/ml soybean trypsin inhibitor (Sigma) and the cells lysed
in PARP buffer. Equal fractions of lysates and TCA-precipitated
supernatants were electrophoresed on a 10% SDS-PAGE gel,
and sgD was detected by Western blot with R7 antibody, as
described above.
Real-time quantitative PCR
Viral preparations were quantified for the immediate early
gene ICP47. All assays were conducted in 50 μl PCR volumes
containing viral samples (2 μl), 200 nM of each primer, 200 nM
probe, and 25 μl TaqMan Fast Universal PCR Master Mix (2×)
(PE Applied Biosystems, Foster City, CA). Primer sequences for
ICP47 (forward: 5′ CAC GAC ATG CTT TTC CCG A 3′;
reverse: 5′ TTC CCG CAG GAG GAA CG 3′) were designed
using the Primer Express program (PE Applied Biosystems). The
TaqMan probe for detection of ICP47 (5′ CGC CGG TCG CCT
CGA CGA 3′) was labeled with fluorescent reporter dye 6-
carboxyfluorescein (6-FAM) at the 5′ end and the quencher dye
carboxytetramethylrhodamine (TAMRA) at the 3′ end (PE
Applied Biosystems). All PCR reactions were set up in a
MicroAmp Optical 96 well Reaction Plate (PE Applied
Biosystems). Amplification conditions were 2 min at 50 °C and
10 min at 95 °C for the first cycle followed by 40 cycles of 95 °C
for 15 s and 60 °C for 1 min. The TaqMan probes were cleaved
during the amplification of target sequence, generating fluores-
cent emission specific for FAM-labeled probes. All samples and
standards were run at least in duplicate and each run contained
both negative (reaction mix with no sample and a sample known
to contain noHSVDNA) and positive controls (samples known to
contain HSV sequence, i.e. an ICP47 plasmid and an HSV
vector). Standard curves were generated using 10-fold serial
dilutions of the ICP47 plasmid. Efficiency of ICP47 primer–
probe set was confirmed previously by side-by-side TaqMan PCR
runs with other HSV genes such as ICP27 present in other KOS-
derived viruses that have also been quantified by negative staining
electron microscope analysis (A. Ozuer, unpublished data). The
emission data were collected in real-time from an ABIPRISM
7000 Sequence Detector System and analyzed using Sequence
Detector Software (PE Applied Biosystems).
Calculation of relative entry efficiencies
Using the TaqMan standard curves described above, the parti-
cle concentrations of our virus stocks were determined as 8.39±
1.26×109/ml for gD− KΔUs3-8Z and 9.03±1.91×1010/ml for
gD-complemented KΔUs3-8Z. By counting transducing events
(blue cells) induced by these preparations on CHO-HVEM
cells, we derived the following transduction efficiencies
(particles/blue cells): approximately 1.1×103 for the gD−
stock in the presence of saturating amounts of sgD and
1.1×102 for the gD-complemented stock. Thus, the difference
in the transduction efficiencies of the two stocks was
approximately 10-fold.
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